Get 20% Free Customization In This Report

Buy this report from - $3456

Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Medical Devices & Supplies	LI_172187	Pages: 151	Apr 2017 \| 1888 Views
Author's : Deepa Tatkare	Tables: 30	Charts: 33	Formats*:

Coronary Stents Market Overview:

Global Coronary Stents Market was valued at $4,806 million in 2015, and is expected to reach at $9,003 million in 2022, registering a CAGR of 9.5% from 2016 to 2022. A coronary stent is a minute tube widely used to open narrowed artery during percutaneous coronary intervention procedure (PCI). This treatment procedure involves insertion of balloon-tipped tube (catheter) into an artery and is carried toward location of blockage. Furthermore, the stent expands and forms a scaffold after inflation of balloon, holding the artery open, and thereby improving the blood flow to the heart. Coronary stents are applicable in treatment of cardiac diseases, such as myocardial infarction, angina pain, and coronary artery disease. The demand for coronary stents has increased significantly, owing to rise in prevalence of coronary artery disease (CAD) globally. In addition, the emergence of innovation in coronary stents further drives the market growth.

Get more information on this report : Request Sample Pages

The global coronary stents market is segmented based on product, biomaterial, end user, and geography. Based on product, it is classified into drug-eluting stent, bare-metal stent, and bio-absorbable vascular stent. Based on biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. Metallic stents are further classified into cobalt chromium (CoCr), platinum chromium (Pt-Cr), stainless steel, and nickel titanium. Based on end user, it is divided into hospital & clinic and ambulatory surgical centers. In metallic biomaterials segment, by type, cobalt chromium occupied dominant share in 2015, and is expected to maintain this trend during the forecast period, owing to features such as high flexibility, unique hydrophilic coating technology, excellent pushing ability, and ideal fitting for the narrow and tortuous lesions.

Get more information on this report : Request Sample Pages

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, rise in R&D of coronary stents and untapped emerging countries are expected to provide new market opportunities to coronary stents manufacturers in the near future.

Get more information on this report : Request Sample Pages

Global Coronary Stents Market Key Product Segment

The metallic biomaterial segment accounted for a significant share in the global coronary stents market in 2015, and is expected to continue this trend during the forecast period.

LAMEA Coronary Stents Market

Rise in incidence of CAD and rapid adoption of coronary stents for the treatment drive the growth of the coronary stents market in LAMEA. However, due to low gross income in countries, such as Latin America, there are less expenditures on the development of new methods and devices for the treatment of CAD. Lack of healthcare facilities and increased need for treatment devices for CAD have increased the penetration of major players in the Middle East region. Nevertheless, the market growth is driven by improvements in healthcare infrastructure and rise in disposable income. Regionally, Saudi Arabia country in LAMEA region showcased the highest CAGR in 2015.

The key players operating in the global coronary stents market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Stentys SA.

The other significant players in the value chain include Meril Life Sciences Pvt. Ltd., Vascular Concepts Limited, Translumina GmbH, REVA Medical, Inc., and Elixir Medical Corporation.

Key Benefits for Stakeholders

The study provides an in-depth analysis of the global coronary stents market, with current trends and future estimations to elucidate the imminent investment pockets from 2014 to 2022.
A quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
Key market players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the market.
Porters Five Forces model elucidates the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Coronary Stents Market Key Segments:

By Product

Drug-Eluting Stent
Bare-Metal Stent
Bioabsorbable Vascular Stent

By Biomaterial

Metallic
- Cobalt Chromium (CoCr)
- Platinum Chromium (Pt-Cr)
- Stainless Steel
- Nickel Titanium
Polymeric Biomaterial
Natural Biomaterial

By End User

Hospital & Clinic
Ambulatory Surgical Centers

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Indonesia
- Thailand
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- South Africa
- Colombia
- Argentina
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.1. Top winning strategies

3.2.1.1. Competitive intelligence of companies and their strategies

3.2.2. Market share analysis, 2016

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Emergence of newer trend in the field of coronary stents
3.3.1.2. Improved clinical outcomes with stenting
3.3.1.3. Rise in prevalence of coronary heart disease
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Availability of alternative treatment methods for coronary heart disease
3.3.2.2. High cost of treatment associated with stent implants
3.3.2.3. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Huge market opportunities in the developing countries

3.4. PORTERS FIVE FORCES ANALYSIS

3.4.1. Bargaining power of buyers
3.4.1. Bargaining power of suppliers
3.4.2. Threat of substitutes
3.4.3. Threat of new entrants
3.4.4. Competitive rivalry

3.5. CLINICAL TRIALS

Chapter: 4 GLOBAL CORONARY STENTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DRUG-ELUTING STENTS (DES)

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. BARE-METAL CORONARY STENTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.1. Market size and forecast

4.4. BIOABSORBABLE STENTS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.1. Market size and forecast

Chapter: 5 GLOBAL CORONARY STENT MARKET, BY BIOMATERIALS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. METALLIC BIOMATERIALS

5.2.1. Market size and forecast

5.3. POLYMERIC BIOMATERIALS

5.3.1. Market size and forecast

5.4. NATURAL BIOMATERIALS

5.4.1. Market size and forecast

Chapter: 6 GLOBAL CORONARY STENTS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS

6.3.1. Market size and forecast

Chapter: 7 GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. Italy market size and forecast
7.3.7. Spain market size and forecast
7.3.8. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. Malaysia market size and forecast
7.4.9. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. South Africa market size and forecast
7.5.6. South Arabia market size and forecast
7.5.7. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. B. BRAUN MELSUNGEN AG.

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. BIOSENSORS INTERNATIONAL GROUP, LTD.

8.3.1. Overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves and developments

8.4. BIOTRONIK SE & CO. KG

8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Key strategic moves and developments

8.5. BOSTON SCIENTIFIC CORPORATION

8.5.1. Overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments

8.6. C. R. BARD, INC.

8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments

8.7. MEDTRONIC PLC.

8.7.1. Overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. MICROPORT SCIENTIFIC CORPORATION

8.8.1. Company Overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. STENTYS SA

8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments

8.10. TERUMO CORPORATION

8.10.1. Overview
8.10.2. Operating business segments
8.10.3. Business performance
8.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. PREVALENCE OF CORONARY HEART DISEASE IN INDIA (2010-2015)
TABLE 2. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. GLOBAL DRUG-ELUTING STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. GLOBAL BARE-METAL STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 5. GLOBAL BIOABSORBALE STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
TABLE 7. GLOBAL METALLIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 8. GLOBAL POLYMERIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 9. GLOBAL NATURAL BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL CORONARY STENTS MARKET, BY END USER, 2014-2022
TABLE 11. GLOBAL HOSPITALS MARKET, BY REGION, 2014-2022
TABLE 12. GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, 2014-2022
TABLE 13. GLOBAL CORONARY STENTS MARKET, BY REGIONS, 2014-2022 ($MILLION)
TABLE 14. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. NORTH AMERICA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 16. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 17. NORTH AMERICA CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 18. COMPETITIVE LANDSCAPE IN EUROPE
TABLE 19. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 20. EUROPE CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
TABLE 21. EUROPE CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 22. EUROPE CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 23. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24. ASIA-PACIFIC CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
TABLE 25. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
TABLE 26. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
TABLE 27. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28. LAMEA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29. LAMEA CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
TABLE 30. LAMEA CORONARY STENTS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 31. ABBOTT: COMPANY SNAPSHOT
TABLE 32. ABBOTT: OPERATING SEGMENTS
TABLE 33. B. BRAUN: COMPANY SNAPSHOT
TABLE 34. B. BRAUN: OPERATING SEGMENTS
TABLE 35. BIOTRONIK: COMPANY SNAPSHOT
TABLE 36. BIOTRONIK: OPERATING SEGMENTS
TABLE 37. BOSTON: COMPANY SNAPSHOT
TABLE 38. BOSTON: OPERATING SEGMENTS
TABLE 39. BARD: COMPANY SNAPSHOT
TABLE 40. BARD: OPERATING SEGMENTS
TABLE 41. MEDTRONIC: COMPANY SNAPSHOT
TABLE 42. MEDTRONIC: OPERATING SEGMENTS
TABLE 43. MICROPORT: COMPANY SNAPSHOT
TABLE 44. MICROPORT: OPERATING SEGMENTS
TABLE 45. STENTYS: COMPANY SNAPSHOT
TABLE 46. STENTYS : OPERATING SEGMENTS
TABLE 47. TERUMO: COMPANY SNAPSHOT
TABLE 48. TERUMO: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. CORONARY STENTS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL CORONARY STENTS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. TOP COMPANIES AND NATURE OF THEIR STRATEGIES
FIGURE 7. TOP COMPANIES AND TYPE OF THEIR STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS: CORONARY STENTS MARKET, 2015
FIGURE 9. BARGAINING POWER OF BUYERS, 2015
FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2015
FIGURE 11. THREAT OF SUBSTITUTES, 2015
FIGURE 12. THREAT OF NEW ENTRANTS, 2015
FIGURE 13. COMPETITIVE RIVALRY, 2015
FIGURE 14. CLINICAL TRIALS FOR CORONARY STENTS (%)
FIGURE 15. GLOBAL CORONARY STENTS MARKET, BY TYPE
FIGURE 16. U.S. CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 17. CANADA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 18. MEXICO CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 19. GERMANY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 20. FRANCE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 21. ITALY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 22. SPAIN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 23. REST OF EUROPE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 24. JAPAN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 25. CHINA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 26. INDIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 27. AUSTRALIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 28. MALAYSIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 29. REST OF ASIA-PACIFIC CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 30. BRAZIL CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 31. SOUTH AFRICA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 32. SOUTH ARABIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
FIGURE 33. REST OF LAMEA CORONARY STENTS MARKET, 2014-2022 ($MILLION)

The adoption of coronary stents, such as bare-metal and biabsorbale stents, is expected to increase in the near future, owing to high prevalence of coronary artery diseases (CAD) and rise in geriatric population. The coronary stents market has gained the interest of healthcare providers due to the benefits offered by these stents in effective treatment of CAD. There have been significant technological advancements in drug-eluting stent (DES) useful in CAD treatment. At present, DES is widely adopted in clinical practice, owing to improved patient outcomes, reduction in chances of restenosis, and stent thrombosis. Asia-Pacific and LAMEA regions are expected to offer lucrative opportunities to the players, as the markets in the developed nations are saturated with large number of coronary stents.

The global market is driven by emergence of new trends in the coronary stent industry, innovation in the coronary stents in terms of coatings & designs, and increase in patient preference for minimally invasive procedures. However, this growth is restricted by high cost of these devices (especially in the developing nations) and availability of substitutes in the market. Conversely, emerging markets of the Asia-Pacific and LAMEA regions are expected to provide several growth opportunities during the forecast period.

At present, many stent manufacturers have ventured into the R&D of bio-absorbable vascular stents (BVS), which is in developmental stage. However, its demand is expected to rise in near future, owing to its several benefits. Limitations are associated with BVS, although with improvement in the device it is expected to be first line of therapy for certain indications as compared to the currently used second-generation DES. In addition, the emerging countries have witnessed rapid increase in the shipments of these coronary devices, resulting in the improvement of their healthcare infrastructure.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Coronary Stents Market Overview: